Analysis of gastric atrophy induced by Helicobacter pylori (H. pylori) infection using serum anti-Helicobacter pylori antibody, anti-Caga antibody, and pepsinogen status

被引：0
|
作者：
Yamaji, Y
Shibata, W
Watabe, H
Yanai, A
Hirata, Y
Mitsuno, Y
Maeda, S
Yoshida, H
Kawabe, T
Omata, M
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)82142-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A424 / A424
页数：1
相关论文
共 50 条
  • [41] Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils
    Chang, Chun-Chao
    Chen, Sheng-Hsuan
    Lien, Gi-Shih
    Lee, Yuarn-Jang
    Lou, Horng-Yuan
    Hsieh, Ching-Ruey
    Fang, Chia-Lang
    Pan, Shiann
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (07) : 982 - 985
  • [42] Lifestyle and anti-Helicobacter pylori immunoglobulin G antibody among outpatients
    Hamajima, N
    Inoue, M
    Tajima, K
    Tominaga, S
    Matsuura, A
    Kobayashi, S
    Ariyoshi, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (11): : 1038 - 1043
  • [43] Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan
    Saito, Shota
    Azumi, Motoi
    Muneoka, Yusuke
    Nishino, Katsuhiko
    Ishikawa, Takashi
    Sato, Yuichi
    Terai, Shuji
    Akazawa, Kouhei
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (04): : 545 - 555
  • [44] Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan
    Shota Saito
    Motoi Azumi
    Yusuke Muneoka
    Katsuhiko Nishino
    Takashi Ishikawa
    Yuichi Sato
    Shuji Terai
    Kouhei Akazawa
    The European Journal of Health Economics, 2018, 19 : 545 - 555
  • [45] Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study
    Toyoshima, Osamu
    Nishizawa, Toshihiro
    Sakitani, Kosuke
    Yamakawa, Tadahiro
    Takahashi, Yoshiyuki
    Yamamichi, Nobutake
    Hata, Keisuke
    Seto, Yasuyuki
    Koike, Kazuhiko
    Watanabe, Hidenobu
    Suzuki, Hidekazu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (35) : 4061 - 4068
  • [46] Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis
    Shen, Huili
    Chen, Yijie
    Li, Xiaohui
    Yan, Jing
    Zhao, Junjie
    Kong, Demin
    Shi, Yanxia
    Li, Zhihui
    Wang, Jihong
    Shao, Na
    Wang, Zhenghui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [47] Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations
    Yu, Jin-Han
    Zhao, Ying
    Wang, Xiao-Feng
    Xu, Ying-Chun
    DIAGNOSTICS, 2022, 12 (05)
  • [48] Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study
    Osamu Toyoshima
    Toshihiro Nishizawa
    Kosuke Sakitani
    Tadahiro Yamakawa
    Yoshiyuki Takahashi
    Nobutake Yamamichi
    Keisuke Hata
    Yasuyuki Seto
    Kazuhiko Koike
    Hidenobu Watanabe
    Hidekazu Suzuki
    World Journal of Gastroenterology, 2018, (35) : 4061 - 4068
  • [49] HELICOBACTER PYLORI AND PREECLAMPSIA: ROLE OF ANTI-CAGA ANTIBODIES ON PLACENTAL DEVELOPMENT
    Di Simone, N.
    Tersigni, C.
    Di Nicuolo, F.
    Castellani, R.
    Bugli, F.
    Gasbarrini, A.
    Scambia, G.
    Franceschi, F.
    HELICOBACTER, 2014, 19 : 88 - 88
  • [50] Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection
    Suzuki, H
    Nomura, S
    Masaoka, T
    Goshima, H
    Kamata, N
    Kodama, Y
    Ishii, H
    Kitajima, M
    Nomoto, K
    Hibi, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 185 - 192
12345